Treatment of functional dyspepsia

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 3, 1998, Pages 573-586

  Veldhuyzen Van Zanten, Sander J O ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antacids; Cisapride; Domperidone; Dyspepsia; Functional dyspepsia; H2 receptor antagonists; Helicobacter pylori; Meta analysis; Non ulcer dyspepsia; Omeprazole; Review

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; CIMETIDINE; CISAPRIDE; CLARITHROMYCIN; DOMPERIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ARTICLE; DRUG EFFICACY; DYSPEPSIA; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; SYMPTOM;

EID: 0031761579     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90025-2     Document Type: Article

References (77)

1. Alam K, Schubert TT, Bologna SD & Ma CK (1992) Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. American Journal of Gastroenterology 87: 424-428.
2. Anand BS, Raed AK, Malaty HM et al (1996). Low point prevalence of peptic ulcer in normal individuals with H. pylori infection. American Journal of Gastroenterology 91: 1112-1115.
3. Armstrong D (1996) H. pylori and dyspepsia. Scandinavian Journal of Gastroenterology 31 (supplement 215): 38-47.
4. Axon ATR (1997) Chronic dyspepsia: who needs endoscopy? Gastroenterology 112: 1376-1380.
5. Bernersen B, Johnsen R, Bostad L et al (1992) Is Helicobacter pylori the cause of dyspepsia? British Medical Journal 304: 1276-1279.
6. Bodger K, Daly MJ & Heatley RV (1996) Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners. Alimentary Pharmacology and Therapeutics 10: 889-895.
7. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 343: 811-816.
8. Carlsson R, Galmiche JP, Dents J et al (1997) Prognostic factors influencing relapse of esophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Alimentary Phamacology and Therapeutics 11: 473-482.
9. Carlsson R, Dent J, Watts R et al and the International GORD Study Group (1998) Gastroesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. European Journal of Gastroenterology and Hepatology 10: 119-124.
10. Champion MC, MacCannell K, Thomson A et al (1997). A double-blind randomized study of cisapride in the treatment of non-ulcer dyspepsia. The Canadian cisapride NUD study group. Canadian Journal of Gastroenterology 11: 127-134.
11. Christie J, Shepherd NA, Codling BW & Valori (1997) Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 41: 513-517.
12. Delattre M, Malesky M & Prinzie A (1985) Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Current Therapeutic Research 37: 980-991.
13. Deruyttere M, Lepoutre L, Heylen H et al (1987) Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clinical Therapeutics 10: 44-51.
14. Dimenas E, Glise H, Ballerback B et al (1995) Well-being and gastrointestinal symptoms among patients referred to endoscopy due to suspected duodenal ulcer. Scandinavian Journal of Gastroenterology 30: 1046-1052.
15. Dobrilla G, Comberlato M, Steele A & Vallaperta P (1989) Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. Journal of Clinical Gastroenterology 11: 169-177.
16. Drossman DA, Thompson G, Talley NJ et al (1991) Identification of subgroups of functional gastrointestinal disorders. Gastroenterology International 4: 145-160.
17. El-Omar EM, Banerjee S, Wirz A & McColl KEL (1996) The Glasgow Dyspepsia Severity Score - a tool for the global measurement of dyspepsia. European Journal of Gastroenterology and Hepatology 8: 967-971.
18. Farup P, Larsen S, Ulshagen K & Osnes M (1991) Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. Scandinavian Journal of Gastroenterology 26: 1209-1216.
19. François De Nutte N (1987) Nonulcer dyspepsia: effect of the gastrointestinal prokinetic drug cisapride. Current Therapeutic Research 41: 891-898.
20. Gotthard R, Bodemar G, Brodin U & Jonsson K-A (1988) Treatment with cimetidine, antacids, or placebo in patients with dyspepsia of unknown origin. Scandinavian Journal of Gastroenterology 23: 7-18.
21. Goves H, Oldring JK, Kerr D et al (1998) First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Alimentary Phamacology and Therapeutics 12: 147-157.
22. Graham DY, Malaty HM, Evans DG et al (1991) Epidemiology of H. pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status. Gastroenterology 100: 1495-1501.
23. Guyatt GH, Veldhuyzen van Zanten SJO, Feeney DH & Patrick DL (1989) Measuring quality of life in clinical trials. A taxonomy and review. Canadian Medical Association Journal 140: 1441-1448.
24. Haarmann K, Lebkuchner F, Widmann A et al (1979) A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress. Postgraduate Medical Journal 55(S1): 24-27.
25. Hallerback B, Unge P, Carling Let al and the Scandinavian Clinics for United Research Group (1994) Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 197: 1305-1311.
26. Hansen JM, Bytzer P & Schaffalitzky de Muckadell OB (1998) Placebo-controlled trial of cispride and nizatidine in unselected patients with functional dyspepsia. American Journal of Gastroenterology 93: 368-374.
27. Hausken T & Berstad A (1992) Cisapride treatment of patients with nonulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 27: 213-217.
28. Johannessen T, Fjosne U, Kleveland P et al (1988) Cimetidine responders in non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 23: 327-336.
29. Johannessen T, Kristensen P, Petersen H et al (1991) The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, singlesubject trials. Scandinavian Journal of Gastroenterology 26: 974-980.
30. Khulusi S, Mendall MA, Patel P et al (1995) Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer. Gut 37: 319-324.
31. Klauser A, Voderholzer WA, Knesewitsch PA et al (1993) What is behind dyspepsia. Digestive Diseases and Sciences 38: 147-154.
32. Laheij RJF, Jansen JBMJ, van De Lisconk EH et al (1996) Symptom improvement through eradication of H. pylori in patients with non-ulcer dyspepsia. Alimentary Phamacology and Therapeutics 10: 843-850 (review).
33. Lambert JR (1993) The role of H. pylori in non-ulcer dyspepsia. A debate - for. Gastroenterology Clinics of North America 22: 141-151.
34. Louis TA, Lavori PW, Bailor JC & Polansky M (1984) Crossover and self-controlled designs in clinical research. New England Journal of Medicine 310: 24-31.
35. McCarthy C, Patchett S, Collins RM et al (1995) Long term prospective study of H. pylori in non-ulcer dyspepsia. Digestive Diseases and Sciences 40: 114-119.
36. McColl KEL, El-Nujumi A, Murray L et al (1997) The H. pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 40: 302-306.
37. McColl KEL, Murray LS, El-Omar E et al (1998) UK MRC trial of Helicobacter pylori eradication therapy for non-ulcer dyspepsia. Gastroenterology 114: A222 (G0908).
38. Mason I, Millar LJ, Sheikh RR et al (1998) The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Alimentary Phamacology and Therapeutics 12: 263-271.
39. Meineche-Schmidt VE & Krag E (1997) Antisecretory therapy in 1017 patients with ulcer-like or reflux-like dyspepsia in general practice. European Journal of General Practice 3: 125-130.
40. van de Mierop L, Rutgeerts L, Van de Langenbergh B & Staessen A (1979) Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 19: 244-250.
41. Nesland A & Berstad A (1985) Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scandinavian Journal of Gastroenterology 20: 629-635.
42. Nyrén O, Adami HO, Bates et al (1986) Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. New England Journal of Medicine 314: 339-343.
43. Nyrén O, Adami HO, Bates S et al (1987) Self-rating of pain in nonulcer dyspepsia. Journal of Clinical Gastroenterology 9: 408-414.
44. Nyrén O, Lindberg G, Lindstrom E et al (1992) Economic costs of functional dyspepsia. PharmacoEconomics, pp 312-324. Adis International.
45. Ofman JJ, Etchason J, Fullerton S et al (1997) Management strategies for H. pylori-seropositive patients with dyspepsia: clinical and economic consequences. Annals of Internal Medicine 126: 280-291.
46. Patchett S, Beattie S, Leen E et al (1991) Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. British Medical Journal 303: 1238-1240.
47. Rösch W (1987) Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scandinavian Journal of Gastroenterology 22: 161-164.
48. Rösch W (1989) Efficacy of cisapride in the treatment of epigastric pain and concomitant symptoms in non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 24(8165): 54-58.
49. Sandha GS & Veldhuyzen van Zanten SJO (1998) A systematic overview of the use of diary cards, quality of life questionnaires and psychometric tests in the treatment trials of Helicobactor pylori positive and negative non-ulcer dyspepsia. Gastroenterology 114(4, Part 2): A275 (G1131).
50. Saunders J, Oliver R & Higson D (1986) Dyspepsia: incidence of non-ulcer disease in a controlled trial of ranitidine in general practice. British Medical Journal 292: 665-668.
51. Sheu B-S, Lin C-Y, Lin X-Z et al (1996) Long-term outcome of triple therapy in H. pylori-related non-ulcer dyspepsia: a prospective controlled assessment. American Journal of Gastroenterology 91: 441-447.
52. Sonnenberg A (1996) Cost-benefit analysis of testing for H. pylori in dyspeptic subjects. American Journal of Gastroenterology 91: 1773-1777.
53. Talley NJ (1991) Drug treatment of functional dyspepsia. Scandinavian Journal of Gastroenterology 26(8182): 47-60.
54. Talley NJ (1993) The role of H. pylori in non-ulcer dyspepsia. A debate-against. Gastroenterology Clinics of North America 22: 153-167.
55. Talley NJ (1994) A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia. Gastroenterology 106: 1174-1183.
56. Talley NJ & Hunt RH (1997) What role does H. pylori play in dyspepsia and non-ulcer dyspepsia: arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 113: S67-S77.
57. Talley NJ & Phillips SF (1988) Non-ulcer dyspepsia: potential causes and pathophysiology. Annals of Internal Medicine 108: 865-879.
58. Talley NJ, McNeil D, Hayden A & Piper DW (1986) Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 91: 149-156.
59. Talley NJ, Zinsmeister AR, Schleck CD & Melton LJ (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102: 1259-1268.
60. Talley NJ, Colin-Jones D, Koch KL et al (1991) Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International 4: 145-160.
61. Talley NJ, Weaver AL, Tesmer DL & Zinsmeister A (1993a) Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105: 1378-1386.
62. Talley NJ, Nyrén O, Drossman DA et al (1993b) Functional gastrointestinal disorders: toward optimal design of controlled treatment trials, with special reference to the irritable bowel syndrome. Gastroenterol International 6: 189-211.
63. Talley NJ, Meineche-Schmidt V, Pare P et al (1998a) Omeprazole is efficacious in non-ulcer dyspepsia. Canadian Journal of Gastroenterology 12 (supplement): 70A-71A. Alimentary Pharmacology and Therapeutics (in press).
64. Talley NJ, Meineche-Schmidt V, Pare P et al (1998a) Omeprazole is efficacious in non-ulcer dyspepsia. Canadian Journal of Gastroenterology 12 (supplement): 70A-71A. Alimentary Pharmacology and Therapeutics (in press).
65. Talley NJ, Silverstein MC, Agréus L et al (1998b) AG A Technical Review: Evaluation of dyspepsia. Gastroenterology 14: 582-595.
66. Talley NJ, Janssens J, Lauritsen K et al (1998e) Long-term follow-up of patients with non-ulcer dyspepsia after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 114: A305 (G1249).
67. Trespi E, Broglia F, Villani L et al (1994) Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after H. pylori eradication. Scandinavian Journal of Gastroenterology 29: 884-888.
68. Vaira D, Miglioli M, Mule Pet al (1994) Prevalence of peptic ulcer in H. pylori positive blood donors. Gut 35: 309-312.
69. Veldhuyzen van Zanten SJO (1993) A systematic overview (meta-analysis) of outcome measures in patients with Helicobacter pylori gastritis trials and functional dyspepsia. Scandinavian Journal of Gastroenterology 28(8199): 40-43.
70. Veldhuyzen van Zanten SJO (1995) H. pylori, socioeconomic status, martial status and occupation. Alimentary Phamacology and Therapeutics 9(S2): 41-44.
71. Veldhuyzen van Zanten SJO (1997) The role of H. pylori in NUD? Scandinavian Journal of Gastroenterology 11(51): 63-69.
72. Veldhuyzen van Zanten SJO, Jones M & Talley NJ (1998) Cisapride for treatment of non-ulcer dyspepsia: a meta-analysis of randomized controlled trials. Gastroenterology 114(4, Part 2): A323 (G 1322).
73. Veldhuyzen van Zanten SJO, Tytgat KMAJ, Pollak PT et al (1993). Can severity of symptoms be used as outcome measures in trials of non-ulcer dyspepsia and Helicobacter pylori? Journal of Clinical Epidemiology 46: 273-279.
74. Veldhuyzen van Zanten SJO, Malatjalian D, Tanton R et al (1995) The effect of eradication of H. pylori on symptoms of non-ulcer dyspepsia: a randomized double-blind placebo controlled trial. Gastroenterology 108(4): A250.
75. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ et al (1996) Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. American Journal of Gastroenterology 91: 660-671.
76. Venables TL, Newland RD, Patel AC et al (1997). Omeprazole 10 mg once daily, omeprazole 20 mg once daily, or ranitidine 150mg twice daily, evaluated as initial therapy for the relief of symptoms of gastro-esophageal reflux disease in general practice. Scandinavian Journal of Gastroenterology 32: 965-973.
77. Verdu EF, Armstrong D, Idstrom JP et al (1995) Effect of curing H. pylori infection on intragastric pH during treatment with omeprazole. Gut 37: 743-748.